Nymox Pharmaceutical Corp (NASDAQ:NYMX)

3.65
Delayed Data
As of 4:00pm ET
 -0.13 / -3.44%
Today’s Change
3.00
Today|||52-Week Range
4.69
+10.61%
Year-to-Date
No recent news for Nymox Pharmaceutical Corp.

Today’s Trading

Previous close3.78
Today’s open3.76
Day’s range3.57 - 3.80
Volume137,831
Average volume (3 months)161,280
Market cap$225.4M
Data as of 4:00pm ET, 05/21/2018

Growth & Valuation

Earnings growth (last year)+7.14%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)-21.02%
P/E ratioNM
Price/Sales775.62
Price/Book--

Competitors

 Today’s
change
Today’s
% change
ATHXAthersys Inc+0.08+3.27%
MNOVMediciNova Inc0.000.00%
OBSVObseva SA-0.51-3.83%
NLNKNewLink Genetics Cor...+0.05+0.99%
Data as of 4:00pm ET, 05/21/2018

Financials

Last reporting dateMarch 11, 2016
EPS forecast (this quarter)-$0.11
Annual revenue (last year)$224.0K
Annual profit (last year)-$13.4M
Net profit margin-5,995.09%

Profile

Sector
Health Technology
Industry
Medical Specialties
Chairman, President &
Chief Executive Officer
Paul Averback
Chief Financial Officer
Erik Danielsen
Corporate headquarters
Nassau, New Providence

Forecasts